CombiGene announces outcome in rights issue
April 6, 2021
The information in this press release is not intended for publication, public release or distribution, directly
The information in this press release is not intended for publication, public release or distribution, directly
The board of directors of CombiGene AB (publ) (“CombiGene”) has prepared an EU Growth Prospectus relating
The board of directors of CombiGene AB (publ) (“CombiGene”) has today, based on the authorisation from
On 18 February 2020, and on 24 April 2020, CombiGene AB (publ) (“CombiGene”) issued, inter alia,
Today, the exercise period for subscription of shares in CombiGene AB (publ) (“CombiGene” or the “Company”)
The board of directors of CombiGene AB (publ) (“CombiGene”) has, on the basis of an authorization
On August 31, 2020 the period for exercising warrants of series TO 3 for subscription of
Today, the exercise period for subscription of shares in CombiGene AB (publ) (“CombiGene”) begins on the
CombiGene AB (publ) (“CombiGene” or the “Company”) has today decided to carry out a directed share
CombiGene AB (publ) (”CombiGene” or the ”Company”) has today resolved to conduct a private placement of